Key Insights

Highlights

Success Rate

58% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 85/100

Termination Rate

17.9%

5 terminated out of 28 trials

Success Rate

58.3%

-28.2% vs benchmark

Late-Stage Pipeline

7%

2 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed with results

Key Signals

58% success

Data Visualizations

Phase Distribution

21Total
Not Applicable (11)
Early P 1 (2)
P 1 (4)
P 2 (2)
P 4 (2)

Trial Status

Completed7
Unknown7
Terminated5
Recruiting4
Withdrawn2
Active Not Recruiting2

Trial Success Rate

58.3%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (28)

Showing 20 of 20 trials
NCT07154667Not ApplicableRecruiting

Evaluation of the Auryzon™ EAR 2.0 System in Ear Reconstruction

NCT06078566Phase 1TerminatedPrimary

Long-Term Follow-Up Study of Unilateral Microtia Patients Implanted With AUR-201

NCT06072040Phase 1TerminatedPrimary

Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia

NCT06225336Phase 1TerminatedPrimary

Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia (Australia)

NCT05929976Recruiting

InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort

NCT05288790Phase 2RecruitingPrimary

Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT

NCT05963659Not ApplicableCompletedPrimary

Nitrate Modulates Cognitive Impairment Via Oral Microbiota.

NCT06394687Not ApplicableActive Not Recruiting

The Digestion of Protein Powders in Healthy Participants Using SIMBA and LIMBA Capsule

NCT06763991Not ApplicableNot Yet RecruitingPrimary

Safety and Efficacy of Connecting the Residual Ear to the Cartilage Scaffold in First- vs. Second-Stage Surgery

NCT03729427Not ApplicableWithdrawn

Rib Microtia and the Erector Spinae Plane (ESP) Block

NCT03624608Not ApplicableTerminated

Evaluation of the Auryzon Devices in the Optimization of Ear and Nose Reconstruction Procedures

NCT03771066Not ApplicableCompleted

Bisphenol A and Muscle Insulin Sensitivity

NCT06087874Phase 2Recruiting

Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice

NCT04351893CompletedPrimary

Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology

NCT02224677Completed

Craniofacial Microsomia: Longitudinal Outcomes in Children Pre-Kindergarten (CLOCK)

NCT04399239Phase 1TerminatedPrimary

AuriNovo for Auricular Reconstruction

NCT06289283Active Not Recruiting

Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Cancer Tissues From Male Patients and Urine of Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder

NCT06220994Unknown

the Gut Microbiome and Metabolomics in Chronic Lower extreMities Threatening Ischemia

NCT05417360Not ApplicableCompleted

Akkermansia and Weight Maintenance

NCT05714566Unknown

Research on Gut Microbiome and Metabolomics Alterations in C.Difficile Infected IBD Patients

Scroll to load more

Research Network

Activity Timeline